Comment by
jboom70 on Oct 25, 2021 8:42am
No one here? I see $45-$50 buyout but hope for a staight share for share with Bristol as they have pulled back. Thoughts?
Comment by
TimeScape on Oct 26, 2021 12:51am
The AUPH stock price was $22 before the rumour came out on Friday. A 50% premium would get get it to $33. I doubt an offer would be for much more than that. Maybe $35. AUPH hasn't got much of a pipeline. The lupus nephritis indication is excellent, and they should get a big market share, but it's not a huge market.
Comment by
jboom70 on Oct 26, 2021 5:10am
Current Sp was heavily manipulated by short sellers. Treatment is est @ $62000 yr but Ive also seen $90000as a price. Gets big fast with decent market penetration, say 30% of 300,000 and that's just one yr. Plus you have lic in other countries. A large Pharm Co. could also push more Ins. Co's acceptance.
Comment by
TimeScape on Oct 26, 2021 6:37pm
RBC upped their target price from $23 to $34 US today. I'd be pretty happy with that price on a takeover.
Comment by
ZoranSto on Oct 28, 2021 10:21am
Yes that would be great :-)
Comment by
jboom70 on Oct 29, 2021 1:40am
Now talk of multiple biders @ +$40